Postmenopausal women with diabetes taking thiazolidinediones (TZDS), including rosiglitazone and pioglitazone, may be at increased risk for fractures according to a new study accepted for publication in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Men with diabetes taking both loop diuretics and TZDs may also be at increased risk of fractures.
Science Brief thanks to EurekAlert.
Read more here:
Popular diabetes drugs associated with fractures in type 2 diabetic patients
Net News Publisher for Science News
Related articles by Zemanta
- Increased Cancer Risk of People with Type 2 Diabetes (netnewspublisher.com)
- Intervention Lowered Obesity Rate in Youth At High Diabetes Risk, HEALTHY Study Finds (netnewspublisher.com)
- Healthier Cafeteria Food, More Intense Gym Classes Lower Students’ Diabetes Risk (netnewspublisher.com)
